Po studiji klinike Mayo je cepivo

Moderne 2x bolj ucinkovito kot Pfizer,ucinkovitost Pfizerja je 46 %, miderne pa 78,studija je bila opravljena na 25000 ljudeh,….zato siljenje pfizerja z pozivitvenim odmerkom…90 % in vec zascita o cemer opleta nas NIJAZ ni nikjer omenjena…ce to primrjamo s cepivom za gripo kjer je variacija me 12 in 60 % se dobi sirsa slika…da tega da so cepljeni bazen za neovirsn prenos virusa sploh ne omenjam….tok o lazeh kreka in logarjeve

Ne rabimo povezave do študije, ti kar na besedo vse verjamemo. Za nas je to dovolj! Fašisti! SDS troli! Koprive naj padejo!

A brand-new study indicates some possibly troubling news concerning COVID-19. Based on a study in preprint, a poor performance from Pfizer’s mRNA vaccine has appeared in the July data and could indicate Delta-driven trouble ahead. In sum, the July data produced by this Mayo Clinic and nference retrospective study suggests that Pfizer’s vaccine product known as BNT162b2 was only 42% effective against infection, which has led to some sources for White House officials to sit up and take notice. The study looked at the effectiveness of the Pfizer and Moderna vaccines inside the Mayo Clinic Health System during the January to July period. Moderna’s vaccine was 86% effective against infection for the entire study period, and Pfizer’s was 76%. Yet in July, Moderna was 76% effective, and Pfizer declined to a troubling 42%. These findings were based on Minnesota data, and at least some suggest Delta was dominant at the time. Experts don’t know if this means that the vaccines are less effective over time, less effective against Delta, or perhaps another reason. Venky Soundararajan, a lead author of the study, notes that “Based on the data that we have so far, it is a com…

ameri promovirajo svoje cepvio, kuga novte povedal novga . zabiti runknli.

In zopet članek, ki pove čisto nekaj drugega kot trdi avtor teme. Hecno kako to gre, kajneda?

Ti sploh znaš angleško? Pove točno to, kar trdi avtor. Kar tudi pojasnjuje, zakaj imajo v Izraelu večje probleme kot drugje – tam so cepili izključno s Pfizerjem.

In tudi pri nas je ogromno cepljenih s Pfizerjem. V našem ZD Moderne sploh imeli niso.

Vse kaže, da zna biti tudi Astra Zeneca učinkovitejša od Pfizerja proti delti.

Sami kavc – pametovalci.

Trikrat se zadaneš s Pfizerjem in dosežeš 138 odstotno učinkovitost.

Argument?

imajo prav. Kaj pa vaša stroka? Je kaj imela prav? Vsaj do sedaj?!

Stroka pravi, če zdravilo ne pomaga, je treba povečat dozo. Enkrat bo že prijelo.

točno to. Če ni materiala, naj se naredi intervetni uvoz konjskih injekcij. Za vse je denar, samo za šprice ga ni.

butl, preberi natančno kaj piše. Gre za nerevidirano raziskavo, v kateri ugotavljajo učinkovitost na cepljenih oseb v januarju 2021. Ugotavljajo, da po 5 mesecih od cepljenja sta cepivi enakovredni, po 6 mesecih pa učinkovitost BioNtech drastično pade.

Tako da, Biden nima druge možnosti kot da kupuje cepivo samo od prijateljev iz Moderne. Pa koga to nategujejo?

V EU bo pa ravno obratna nerevidirana študija. Moderna bo samo 25% učinkovita, BioNtech pa 86%.

Še enkrat gledam ta graf in čudn, po petih mesecih je cepivo BioNtech bistveno bolj učinkovito kot moderna, ampak po 6ih pa ne več. Kolk ti prijatelji od Bidena manipulirajo. TRUMP, pridi nazaj, pogrešamo te.

Glede na to nenaden porast števila okužb v Izraelu bodo cifre kar držale. Ne  nujno, ker bi se učinkovitost Pfizerja v samo enem mesecu tako drastično znižala, ampak ker se je takrat razširil sev delta, proti kateremu je Pfizer zelo neučinkovit – kar lepo piše v članku.

Zbral nekaj študij za Pfizer na Delto varianto

Public Health England 88%

journal Nature  95%

Canada 87%

Škotska 79%

Izrael 64%

India 88%

Mayo 42%

Če povzamemo

Data so far suggests efficacy rates of more than 67 percent for the J&J vaccine, 72 to 95 percent for the Moderna vaccine, and 42 to 96 percent for the Pfizer-BioNTech vaccine.

Xy% učinkovitost? Deluje ali pa ne. Bacil je enak pri vseh ljudeh. Zdaj na Lojzetu deluje, na Poldetu pa ne. Koga imate za norca? Tile procenti in lažji potek bolezni so en težak nateg, za katerim se skriva neučinkovitost zvarkov.

Študij za delto sploh ni. Navajaš stare cifre.

Indija ima z obema dozama precepljenega 10 % prebivalstva. Kako so potem sploh prišli do teh podatkov? Krneki.

Public Health of England – edina obsežna študija je bila izvedena za Alfo, ne delto!

Sploh pa so vse te študije navaden bulšit – bistveno je samo realno stanje okužb in hospitalizacij – dokler seveda številk ne prirejajo oziroma prirejajo statistiko.

In cifre s terena so katastrofalne.

Škotska – do cifre so prišli po drugi dozi cepiva. Verjetno takrat, ko je zaščita največja. Res relevanten podatek, glede na to, da sčasoma učinkovitost hitro pada. Ni bilo nobene študije. Za real-time analysis pa škotski raziskovalci navajajo tisto, ki je že bila objavljena tukaj – Lancet in navaja zaščito cepiva pred hospitalizacijo do največ 3 %.

In community cases at least two weeks after the second dose, the Pfizer-BioNTech vaccine was found to provide 79 per cent protection against infection from the Delta variant, compared with 92 per cent against the Alpha variant.

The research team from Universities of Edinburgh and Strathclyde and Public Health Scotland, analysed a dataset as part of the EAVE II project, which uses anonymised linked patient data to track the pandemic and the vaccine roll out in real time.

The results are published as a research letter in The Lancet. 

Alfa, delta, beta…. Vse je nateg.

Koliko debilov še vas vedno verjame v ta nateg?

Ma daj ne bluzi. Tričetrt teh raziskav vsaj posredno financira farmacija ali pa so njihovi avtorji tako ali drugače financirani z njihove strani. Vzamejo tiste vzorce, številke ali čas, ki njim ustreza, ostalo pa gladko ‘spregledajo’.

Nenazadnje, lipov čaj ščiti tako, da 3/4 ni praktično nič, nekaj je hospitaliziranih, od tega jih 0,0? umre (posledice predno se je pojavil zvarek). Ergo, lipov čaj ima boljši procent zaščite kot Pfizer zvarek.

This week, the European Medicines Agency (EMA) initiated an investigation into the potential association between mRNA vaccines such as the Pfizer-BioNTech Comirnaty and new adverse events reported on the continent by at least a handful of vaccine recipients. Do these jabs pose any threats? For example, do the shots lead to kidney issues or dermatological issues such as a skin reaction? In the meantime, Ukrainian authorities want to know if a man’s death after a jab was associated with the vaccine. The reality: some people will die from these vaccines, and that was all but directly acknowledged by the Australian drug authority.

First to Australia—recently their drug regulator, the Therapeutic Goods Administration (TGA), infused a fresh, honest reality, unlike any other regulatory body we have observed. The TGA declared in a recent weekly safety report that “Large scale vaccination means that coincidentally some people will experience a new illness or die shortly after vaccination.” We ask, why only coincidentally?

Reuters reported that in Ukraine, a man received the Pfizer-BioNTech vaccine and died just hours after the jab. Apparently, the authorities were quick to suggest that “the death may have no connection to the shot.” After all, another five people were vaccinated with a product from the same vial, and all were OK. But that probably isn’t the problem; it’s some kind of specific response. The Ukrainian authorities follow the law there and will investigate.

Pa še en zanimiv fenomen – medtem ko se precepljeni Izrael utaplja v okužbah, ima polne bolnišnice, vlada panika, govora je o tem, da ne bi odprli šol – v Palestini vse po starem – brez mask, brez socialne distance, skoraj brez cepljenja.

Preprosto zato, ker se jih je v prejšnjih valovih toliko prekužilo, da je veliko prebivalcev imunih. In šole se bodo normalno odprle.